Best super fund
We’ve won a string of accolades from Australia’s top ratings and research agencies.
We’ve been named Money magazine’s Best Growth Super Product 2024 and Best Pension Fund for both 2023 and 2024.
We’re a SuperRatings 15 Year Platinum Performance Fund 2009-2024 (Flexi Pension, Accumulation 1 and Accumulation 2) and Chant West’s Super Fund of the Year 2023.
Canstar recognised us with their Outstanding Value Superannuation Awards 2022 to 2024 and their Most Satisfied Customers Award for Superannuation Funds 2023.
Our award wins
Canstar’s 2023 Most Satisfied Customers: Super Fund Award, Outstanding Value Award – Superannuation 2022-2024
Money magazine Best Pension Fund 2023, Best Australian Shares Super Product 2023, Best Shares ESG Super Product 2023, Best Pension Fund 2024, Best Shares ESG Super Product 2024, Best Growth Super Product 2024, and Best Fixed-Interest Super Product 2024.
SuperRatings Fund of the Year 2024, MyChoice Super of the Year 2024, Choice Insurance Offering 2024, Sustainable Fund of the Year 2024, SuperRatings Platinum 2024 MySuper, SuperRatings Platinum 2024 Pension, 15 Year Platinum Performance 2009-20241
Chant West Super Fund of the Year 2023, Chant West Super Fund of the Year 2022, Chant West Best Fund: Advice Services 2022, Best Fund: Investments; Finalist 2014 - 20232
Mozo People’s Choice Awards – Outstanding Customer Satisfaction 2022 and 2021, People’s Choice Awards – Competitive Fees 2022 and 2021, People’s Choice Awards – Most Recommended 2022 and 2021, People’s Choice Awards – Investment Choice 2022 and 2021, People’s Choice Awards – Highly Trusted 2022, People’s Choice Awards – Insurance Cover 2022
Rainmaker AAA Quality Rating 2024, 2023, 2022 and 2021, ESG Leader 2023, 2022
Roy Morgan Customer Satisfaction Award for Industry Superannuation Fund of the Year 2023, Superannuation Fund of the Year 2023
-
Things you need to know
1 SuperRatings
The rating is issued by SuperRatings Pty Ltd (SuperRatings) ABN: 95 100 192 283 a Corporate Authorised Representative (CAR No.1309956) of Lonsec Research Pty Ltd ABN 11 151 658 561, AFSL No. 421445 (Lonsec Research). Ratings are general advice only and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and SuperRatings assumes no obligation to update. SuperRatings uses objective criteria and receives a fee for publishing awards. Visit superratings.com.au for ratings information and to access the full report. © 2024 SuperRatings. All rights reserved.
2 Chant West
Zenith CW Pty Ltd ABN 20 639 121 403 AFSL 226872/AFS Rep No. 1280401 Chant West Awards issued May 2023 are solely statements of opinion and not a recommendation in relation to making any investment decisions. Awards are current for 12 months and subject to change at any time. Awards for previous years are for historical purposes only. Full details on Chant West Awards at chantwest.com.au.
3 Super Review
© 2021 FE Money Management. all rights reserved. The information, data, analysis, and opinions contained herein (1) include the proprietary information of FE Money Management (2) may not be copied or redistributed (3) do not constitute investment advice offered by FE Money Management (4) are provided solely for informational purposes and therefore are not an offer to buy or sell a security (5) are not warranted to be correct, complete, or accurate. FE Money Management shall not be responsible for any trading decisions, damages, or other losses resulting from, or related to, this information, data, analyses, or opinions or their use. FE Money Management does not guarantee that a fund/product will perform in line with its Super Fund of the Year award as it reflects past performance only. Likewise, the Super Fund of the Year award should not be any sort of guarantee or assessment of the creditworthiness of a product/fund or of its underlying securities and should not be used as the sole basis for making any investment decision.